C07D 499/24
With acyclic or carbocyclic compounds containing amino radicals
Official title: with acyclic or carbocyclic compounds containing amino radicals
C07D499/24 (With acyclic or carbocyclic compounds containing amino radicals) appears on 4 US grants and 6 published applications in this corpus.
Search patents in C07D- Granted patents
- 4
- Published applications
- 6
- Assignees
- 1
- Inventors
- 2
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 3 |
| 2017 | 3 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,937 B2Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,938 B2Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution28 Mar 2017US 9,603,939 B2Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jun 2021US 2021/0177758 A1Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Mar 2018US 2018/0064649 A1Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution15 Sep 2016US 2016/0263138 A1Theaprin Pharmaceuticals Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution15 Sep 2016US 2016/0263224 A1Theaprin Pharmaceuticals Inc.
Most cited
By later US patents
- Platform drug delivery system utilizing crystal engineering and theanine dissolution2US 9,603,937 B2Theaprin Pharmaceuticals Inc. · 2017
- Platform drug delivery system utilizing crystal engineering and theanine dissolution1US 9,603,938 B2Theaprin Pharmaceuticals Inc. · 2017
- Platform drug delivery system utilizing crystal engineering and theanine dissolution1US 9,603,939 B2Theaprin Pharmaceuticals Inc. · 2017